Herpes is one of the most common infections on the planet. Worldwide, roughly 3.8 billion people under age 50 carry herpes simplex virus type 1 (HSV-1), which works out to about 64% of the global population. HSV-2, the type more closely associated with genital herpes, is less widespread but still affects hundreds of millions of people. In the United States alone, nearly half of adults aged 14 to 49 have HSV-1, and about 12% have HSV-2.
Global and U.S. Numbers
HSV-1 is the dominant strain by a wide margin. The World Health Organization’s most recent estimates, based on 2020 data, put the global HSV-1 infection rate at 64% of everyone under 50. Most people pick it up during childhood through nonsexual contact like kissing or sharing utensils, though it increasingly causes genital infections as well.
In the United States, CDC survey data from 2015 to 2016 found HSV-1 prevalence at 47.8% among people aged 14 to 49, and HSV-2 prevalence at 11.9% in the same age group. That means roughly 1 in 8 Americans in that age range carries HSV-2. Because many people have one or both types, the total number of Americans with some form of herpes is substantially higher than either figure alone suggests.
Most People Don’t Know They Have It
The single most striking fact about herpes prevalence is how invisible it is. In large national surveys, only about 9% of people who tested positive for HSV-2 antibodies knew they were infected. Even in clinical settings where you’d expect more awareness, the numbers aren’t much better. At a Seattle STD clinic, just 34% of HSV-2-positive women were aware of their status. At a family practice in Washington state, only 26% of seropositive patients reported a history of genital herpes. In the U.K., 17% of HSV-2-positive blood donors knew they carried the virus.
This gap between infection rates and awareness exists because herpes often causes mild symptoms that get mistaken for something else, or no noticeable symptoms at all. A small irritation that heals in a few days might never prompt a doctor visit. Standard STI panels typically don’t include herpes testing unless you specifically request it, which further widens the knowledge gap.
HSV-1 Is Increasingly a Genital Infection
HSV-1 has traditionally been thought of as the “cold sore” virus and HSV-2 as the “genital” virus, but that distinction has blurred significantly. Older estimates suggested that 10 to 15% of new genital herpes cases were caused by HSV-1. More recent data tells a different story. A six-year study at a Kentucky medical center found that nearly 30% of culture-positive genital herpes cases were HSV-1. By the final year of that study, HSV-1 accounted for 41.6% of all genital herpes diagnoses, with rates even higher in women (44.8%) than in men (31.8%).
This shift likely reflects changes in when people first encounter HSV-1. As childhood HSV-1 rates have declined in some populations (due to less shared contact and improved hygiene), more teenagers and young adults encounter the virus for the first time through oral sex rather than through childhood kisses. Without existing oral HSV-1 antibodies, the virus can establish itself genitally.
Transmission and Viral Shedding
In couples where one partner has genital herpes and the other doesn’t, transmission is not inevitable but also not rare. One study of such couples found that about 10% of susceptible partners acquired the infection over the study period. The risk was not evenly distributed: women without any prior HSV antibodies had an annual acquisition rate of roughly 32%, while women who already carried HSV-1 antibodies picked up HSV-2 at a rate closer to 9%. Existing HSV-1 antibodies appear to offer partial, though far from complete, protection against HSV-2.
A major reason herpes spreads so effectively is asymptomatic viral shedding. People with HSV-2 shed the virus on roughly 18% of days, and about 80% of that shedding happens when there are no visible sores or symptoms. This means most transmissions occur when the infected partner looks and feels completely fine, which is part of why so many people acquire the virus without any obvious exposure.
Testing and Its Limitations
Blood tests for herpes detect antibodies your immune system produces in response to the virus, not the virus itself. For HSV-2, the most commonly used tests are reasonably accurate, with sensitivity above 90% and specificity above 98% for the better-performing platforms. But there’s an important caveat: results that fall in a “low-positive” range (index values below 3.0) have a much higher rate of false positives. On some testing platforms, more than a third of low-positive HSV-2 results turn out to be wrong. If you receive a low-positive result, confirmatory testing with a different method is worth pursuing before drawing conclusions.
HSV-1 blood testing is less reliable overall, with sensitivity below 85% on some widely used platforms and a particularly high false-positive rate for low-positive results. One system flagged 76% of low-positive HSV-1 results as false positives. This is one reason routine herpes screening isn’t standard practice: in a population where the virus is extremely common and mostly asymptomatic, the potential for confusing or misleading results is high.
Why It Seems Rarer Than It Is
Given that roughly half of American adults carry HSV-1 and one in eight has HSV-2, herpes is far more common than most people assume. The stigma surrounding the diagnosis is disproportionate to its medical significance for the vast majority of carriers. Several factors create the illusion of rarity: most infected people are never diagnosed, routine STI testing doesn’t screen for it, and people who do know their status are often reluctant to discuss it openly. The result is a virus that affects billions of people worldwide while remaining, in most social circles, something that seemingly happens to someone else.